Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 785826, 10 pages
http://dx.doi.org/10.1155/2015/785826
Research Article

Alpha-Mangostin Attenuation of Hyperglycemia-Induced Ocular Hypoperfusion and Blood Retinal Barrier Leakage in the Early Stage of Type 2 Diabetes Rats

1Department of Physiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand
2Biomedical Science Program, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand
3Department of Chemistry, Faculty of Science, Srinakharinwirot University, Bangkok 10110, Thailand
4Department of Microbiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand

Received 9 February 2015; Accepted 25 March 2015

Academic Editor: Hanrui Zhang

Copyright © 2015 Amporn Jariyapongskul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Fowler, “Microvascular and macrovascular complications of diabetes,” Clinical Diabetes, vol. 26, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Konig, E. M. Lamos, S. A. Stein, and S. N. Davis, “An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications?” Current Diabetes Reviews, vol. 9, no. 5, pp. 371–381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Ahsan, “Diabetic retinopathy—Biomolecules and multiple pathophysiology,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 9, no. 1, pp. 51–54, 2015. View at Publisher · View at Google Scholar
  4. J. M. Tarr, K. Kaul, M. Chopra, E. M. Kohner, and R. Chibber, “Pathophysiology of diabetic retinopathy,” ISRN Ophthalmology, vol. 2013, Article ID 343560, 13 pages, 2013. View at Publisher · View at Google Scholar
  5. Y. Wu, L. Tang, and B. Chen, “Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 752387, 12 pages, 2014. View at Publisher · View at Google Scholar
  6. A. K. H. Cheung, M. K. L. Fung, A. C. Y. Lo et al., “Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice,” Diabetes, vol. 54, no. 11, pp. 3119–3125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Bonnardel-Phu, J.-L. Wautier, A. M. Schmidt, C. Avila, and E. Vicaut, “Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo,” Diabetes, vol. 48, no. 10, pp. 2052–2058, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. N. D. Evcimen and G. L. King, “The role of protein kinase C activation and the vascular complications of diabetes,” Pharmacological Research, vol. 55, no. 6, pp. 498–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Rajamani and M. F. Essop, “Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis,” The American Journal of Physiology—Cell Physiology, vol. 299, no. 1, pp. C139–C147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S.-I. Yamagishi, K. Nakamura, and T. Imaizumi, “Advanced glycation end products (AGEs) and diabetic vascular complications,” Current Diabetes Reviews, vol. 1, no. 1, pp. 93–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Chawla, S. Bansal, B. D. Banerjee, S. V. Madhu, O. P. Kalra, and A. K. Tripathi, “Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications,” Microvascular Research, vol. 95, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  12. G. R. Barile and A. M. Schmidt, “RAGE and its ligands in retinal disease,” Current Molecular Medicine, vol. 7, no. 8, pp. 758–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Bierhaus, P. M. Humpert, M. Morcos et al., “Understanding RAGE, the receptor for advanced glycation end products,” Journal of Molecular Medicine, vol. 83, no. 11, pp. 876–886, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. C. B. Moore, J. E. Moore, Y. Kaji et al., “The role of advanced glycation end products in retinal microvascular leukostasis,” Investigative Ophthalmology and Visual Science, vol. 44, no. 10, pp. 4457–4464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Soulis, M. E. Cooper, S. Sastra et al., “Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats,” Diabetologia, vol. 40, no. 10, pp. 1141–1151, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Bucala, K. J. Tracey, and A. Cerami, “Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes,” Journal of Clinical Investigation, vol. 87, no. 2, pp. 432–438, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Pedraza-Chaverri, N. Cárdenas-Rodríguez, M. Orozco-Ibarra, and J. M. Pérez-Rojas, “Medicinal properties of mangosteen (Garcinia mangostana),” Food and Chemical Toxicology, vol. 46, no. 10, pp. 3227–3239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Williams, M. Ongsakul, J. Proudfoot, K. Croft, and L. Beilin, “Mangostin inhibits the oxidative modification of human low density lipoprotein,” Free Radical Research, vol. 23, no. 2, pp. 175–184, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Mahabusarakam, J. Proudfoot, W. Taylor, and K. Croft, “Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin,” Free Radical Research, vol. 33, no. 5, pp. 643–659, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Buelna-Chontal, F. Correa, S. Hernández-Reséndiz, C. Zazueta, and J. Pedraza-Chaverri, “Protective effect of α-mangostin on cardiac reperfusion damage by attenuation of oxidative stress,” Journal of Medicinal Food, vol. 14, no. 11, pp. 1370–1374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Nakatani, M. Atsumi, T. Arakawa et al., “Inhibitions of histamine release and prostaglandin E2 synthesis by mangosteen, a Thai medicinal plant,” Biological and Pharmaceutical Bulletin, vol. 25, no. 9, pp. 1137–1141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. L.-G. Chen, L.-L. Yang, and C.-C. Wang, “Anti-inflammatory activity of mangostins from Garcinia mangostana,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 688–693, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. E. Riva, “Basic principles of laser Doppler flowmetry and application to the ocular circulation,” International Ophthalmology, vol. 23, no. 4–6, pp. 183–189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Xu, T. Qaum, and A. P. Adamis, “Sensitive blood-retinal barrier breakdown quantitation using Evans blue,” Investigative Ophthalmology and Visual Science, vol. 42, no. 3, pp. 789–794, 2001. View at Google Scholar · View at Scopus
  25. M. J. Reed, K. Meszaros, L. J. Entes et al., “A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat,” Metabolism: Clinical and Experimental, vol. 49, no. 11, pp. 1390–1394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Suksamrarn, O. Komutiban, P. Ratananukul, N. Chimnoi, N. Lartpornmatulee, and A. Suksamrarn, “Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 3, pp. 301–305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Chaivisuthangkura, Y. Malaikaew, A. Chaovanalikit et al., “Prenylated xanthone composition of Garcinia mangostana (Mangosteen) fruit hull,” Chromatographia, vol. 69, no. 3-4, pp. 315–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Zhang, X. Y. Lv, J. Li, Z. G. Xu, and L. Chen, “The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model,” Experimental Diabetes Research, vol. 2008, Article ID 704045, 9 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. D. Mooradian, “Dyslipidemia in type 2 diabetes mellitus,” Nature Clinical Practice Endocrinology and Metabolism, vol. 5, no. 3, pp. 150–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Kurniawati, C. Mahdi, and A. Aulanni'am, “The effect of juice mangosteen rind (Garcinia mangostana L.) to blood sugar levels and histological of pancreatic rats with the induction of streptozotocin,” The Journal of Pure and Applied Chemistry Research, vol. 3, no. 1, pp. 1–6, 2014. View at Google Scholar
  32. T. M. Curtis, T. A. Gardiner, and A. W. Stitt, “Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?” Eye, vol. 23, no. 7, pp. 1496–1508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Cai and M. Boulton, “The pathogenesis of diabetic retinopathy: old concepts and new questions,” Eye, vol. 16, no. 3, pp. 242–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Nagaoka, E. Sato, A. Takahashi, H. Yokota, K. Sogawa, and A. Yoshida, “Impaired retinal circulation in patients with type 2 diabetes mellitus: retinal laser doppler velocimetry study,” Investigative Ophthalmology and Visual Science, vol. 51, no. 12, pp. 6729–6734, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Deng, T. Evans, K. Mukherjee, D. Downey, and S. Chakrabarti, “Diabetes-induced vascular dysfunction in the retina: role of endothelins,” Diabetologia, vol. 42, no. 10, pp. 1228–1234, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Takagi, S.-E. Bursell, Y.-W. Lin et al., “Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1,” Investigative Ophthalmology and Visual Science, vol. 37, no. 12, pp. 2504–2518, 1996. View at Google Scholar · View at Scopus
  37. T. Nagaoka and A. Yoshida, “Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease,” Diabetes Care, vol. 36, no. 4, pp. 957–961, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Schmetterer and M. Wolzt, “Ocular blood flow and associated functional deviations in diabetic retinopathy,” Diabetologia, vol. 42, no. 4, pp. 387–405, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. K. K. Griendling and G. A. FitzGerald, “Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS,” Circulation, vol. 108, no. 16, pp. 1912–1916, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kalani, “The importance of endothelin-1 for microvascular dysfunction in diabetes,” Vascular Health and Risk Management, vol. 4, no. 5, pp. 1061–1068, 2008. View at Google Scholar · View at Scopus
  42. A. M. Joussen, V. Poulaki, W. Qin et al., “Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo,” American Journal of Pathology, vol. 160, no. 2, pp. 501–509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Miyamoto, S. Khosrof, S.-E. Bursell et al., “Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10836–10841, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Jariyapongskul, T. Rungjaroen, N. Kasetsuwan, S. Patumraj, J. Seki, and H. Niimi, “Long-term effects of oral vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats,” Microvascular Research, vol. 74, no. 1, pp. 32–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. L. M. Reyes-Fermín, S. González-Reyes, N. G. Tarco-Álvarez, M. Hernández-Nava, M. Orozco-Ibarra, and J. Pedraza-Chaverri, “Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death,” Nutritional Neuroscience, vol. 15, no. 5, pp. 34–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. P. D. Sampath and K. Vijayaraghavan, “Cardioprotective effect of α-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats,” Journal of Biochemical and Molecular Toxicology, vol. 21, no. 6, pp. 336–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Al-Shabrawey and S. Smith, “Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers,” The EPMA Journal, vol. 1, no. 1, pp. 56–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. I. G. Obrosova, L. Fathallah, and D. A. Greene, “Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-α-lipoic acid,” European Journal of Pharmacology, vol. 398, no. 1, pp. 139–146, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Márquez-Valadez, R. Lugo-Huitrón, V. Valdivia-Cerda et al., “The natural xanthone α-mangostin reduces oxidative damage in rat brain tissue,” Nutritional Neuroscience, vol. 12, no. 1, pp. 35–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Pollreisz, B. I. Hudson, J. S. Chang et al., “Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells,” Atherosclerosis, vol. 212, no. 2, pp. 451–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Umadevi, V. Gopi, and E. Vellaichamy, “Inhibitory effect of gallic acid on advanced glycation end products induced up-regulation of inflammatory cytokines and matrix proteins in H9C2 (2-1) cells,” Cardiovascular Toxicology, vol. 13, no. 4, pp. 396–405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. A. K. Mohamed, A. Bierhaus, S. Schiekofer, H. Tritschler, R. Ziegler, and P. P. Nawroth, “The role of oxidative stress and NF-κB activation in late diabetic complications,” BioFactors, vol. 10, no. 2-3, pp. 157–167, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Gao, S. Belmadani, A. Picchi et al., “Tumor necrosis factor-alpha induces endothelial dysfunction in Leprdb mice,” Circulation, vol. 115, no. 2, pp. 245–254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. N. S. Chandel, W. C. Trzyna, D. S. McClintock, and P. T. Schumacker, “Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin,” The Journal of Immunology, vol. 165, no. 2, pp. 1013–1021, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. C. A. Aveleira, C.-M. Lin, S. F. Abcouwer, A. F. Ambrósio, and D. A. Antonetti, “TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability,” Diabetes, vol. 59, no. 11, pp. 2872–2882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S.-I. Yamagishi, K. Nakamura, T. Matsui et al., “Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression,” The Journal of Biological Chemistry, vol. 281, no. 29, pp. 20213–20220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. H. P. Hammes, S. Martin, K. Federlin, K. Geisen, and M. Brownlee, “Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 24, pp. 11555–11558, 1991. View at Google Scholar
  58. H. W. van Dijk, F. D. Verbraak, P. H. Kok et al., “Early neurodegeneration in the retina of type 2 diabetic patients,” Investigative Ophthalmology & Visual Science, vol. 53, no. 6, pp. 2715–2719, 2012. View at Publisher · View at Google Scholar
  59. N. Ashton, “The blood-retinal barrier and vaso-glial relationships in retinal disease.,” Transactions of the Ophthalmological Societies of the United Kingdom, vol. 85, pp. 199–230, 1965. View at Google Scholar · View at Scopus
  60. J. Cunha-Vaz, J. R. Faria de Abreu, and A. J. Campos, “Early breakdown of the blood retinal barrier in diabetes,” British Journal of Ophthalmology, vol. 59, no. 11, pp. 649–656, 1975. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Waltman, T. Krupin, S. Hanish, C. Oestrich, and B. Becker, “Alteration of the blood retinal barrier in experimental diabetes mellitus,” Archives of Ophthalmology, vol. 96, no. 5, pp. 878–879, 1978. View at Publisher · View at Google Scholar · View at Scopus
  62. C. L. Lobo, R. C. Bernardes, J. P. Figueira, J. R. Faria De Abreu, and J. G. Cunha-Vaz, “Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 122, no. 2, pp. 211–217, 2004. View at Publisher · View at Google Scholar · View at Scopus